China Biologic Products, Inc. announced that on May 4, 2014, Dr. Bing Li resigned from the board of directors, effective from May 4, 2014. Dr. Li's resignation was due to personal reasons. On May 4, 2014, the board appointed Mr. Dai Feng, as a director of the company with immediate effect to fill the vacancy resulting from Dr. Li's resignation from the Board.

Mr. Feng has served at Warburg Pincus Asia LLC since 2004. As a managing director, Mr. Feng is responsible for Warburg Pincus's healthcare investment activities in China. He is also a director of PW Medtech Group Limited, EA Inc. and Beijing Amcare Women's and Children's Hospital Co.

Ltd.